You are here

Cancer Australia has developed the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.

Overview

The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders of cancer research to collaboratively fund cancer research in Australia.

This funding scheme helps to:

coordinate funding of priority-driven cancer research at the national level,

foster collaboration between cancer researchers to build Australia’s cancer research capacity, and

foster consumer participation in cancer research, from design to implementation.

Working with the National Health and Medical Research Council (NHMRC)

This research scheme is managed by Cancer Australia and the agency collaborates with the NHMRC in this grant scheme. The NHMRC facilitates registration and initial assessment of applications, and endorses grants funded through this scheme in recognition of their scientific merit.

Phillips, PhoebeUniversity of NSWTherapeutically targeting a solute transported in the stroma of pancreatic cancerFunded by Cancer Australia

Phillips, Phoebe
University of NSWReprogramming the Tumour Microenvironment with the use of Nanomedicines for the Treatment of Pancreatic Cancer
Co-funded by Cancer Australia and Cancer Council Australia

Sahni, Sumit
University of SydneyMolecular Role of the AMPK-Dependent Pathway in the Activity of Thiosemicarbazones Against Pancreatic Cancer.
Funded by Cure Cancer Australia

Sharbeen, George
Lowy Cancer Research CentreMutY-Homolog is a Potential Therapeutic Target for Pancreatic Cancer
Funded by Cure Cancer Australia

Sieber, Oliver
The Walter and Eliza Hall Institute of Medical ResearchDevelopment of a Clinico-Molecular Colon Cancer Nomogram for personalisation of adjuvant chemotherapy in the Australian population
Funded by Cancer Australia